trending Market Intelligence /marketintelligence/en/news-insights/trending/ZBjm9-cIP7IFn9TX8Xt_AA2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

CytoDyn to raise $1.2M from offering


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

CytoDyn to raise $1.2M from offering

CytoDyn Inc. plans to raise approximately $1.2 million via the sale of 1,880,765 shares priced at 65 cents apiece.

The shares will come bundled with 0.5 of a purchase warrant. Each whole warrant will be exercisable for an additional stock in the company at 75 cents apiece.

The biotechnology company intends to use the net proceeds from the transactions to fund clinical trials for its lead product candidate and for general corporate purposes.